Ivax Launches Neurontin Generic “At Risk” As Pregabalin User Fee Date Nears
Executive Summary
Ivax' "at risk" launch of generic gabapentin comes less than two weeks before the anticipated FDA user fee date for Pfizer's Neurontin follow-on drug Lyrica
You may also be interested in...
Pfizer Recalls One Neurontin Lot; Puerto Rico Plant Still Under Consent Decree
Pfizer is recalling 40,000 bottles of Neurontin (gabapentin) from its Vega Baja, Puerto Rico manufacturing facility after patients reported that capsules of the epilepsy drug were insufficiently filled
Pfizer Recalls One Neurontin Lot; Puerto Rico Plant Still Under Consent Decree
Pfizer is recalling 40,000 bottles of Neurontin (gabapentin) from its Vega Baja, Puerto Rico manufacturing facility after patients reported that capsules of the epilepsy drug were insufficiently filled
Generic Price War Remains Strong; Intensity Is Product Specific, Firms Say
Heavy price competition between generic drugs is product specific and company specific, Andrx President-Generic Business Lawrence Rosenthal said